Renuka Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Thane West, Maharashtra, India, established in 2009.
2009 Thane West, Maharashtra, India Struck Off
Last Updated:
About Renuka Pharmaceuticals Private Limited

Renuka Pharmaceuticals Private Limited, a struck off private limited company, was established on 15 May 2009 in Thane West, Maharashtra, India. Engaging in manufacturing within the healthcare sector, it holds CIN: U33100MH2009PTC192413. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Hira Khanderao Sanap (Additional Director), Khanderao Arjun Sanap (Director). Past directors included Sudesh Govind Mahale, Satish Shantaram Tirodkar. It is based at Shop No. 2A, Bal Ganpati Appartment Edalji Raod, Charai, Thane West, Maharashtra, 400601.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100MH2009PTC192413

  • Registration Number

    192413

  • Incorporation Date

    15 May 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 8 Months
Company report

Renuka Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Renuka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Renuka Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Hira Khanderao Sanap Additional Director 03 Aug 2009 Current
Khanderao Arjun Sanap Director 15 May 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 03 Dec 2012 Past
Pramod Abcsdd Director 04 Aug 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Renuka Pharmaceuticals.

Enhance accessibility to Renuka Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Renuka Pharmaceuticals revenue growth over time
Renuka Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Renuka Pharmaceuticals?

Unlock access to Renuka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Renuka Pharmaceuticals?

Unlock and access historical data on people associated with Renuka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Renuka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renuka Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Renuka Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Hira Khanderao Sanap was appointed as a Additional Director was appointed as a Additional Director on 03 Aug 2009 & has been associated with this company since 16 years 6 months . was documented.

  • Director Appointment

    The activity Khanderao Arjun Sanap was appointed as a Director was appointed as a Director on 15 May 2009 & has been associated with this company since 16 years 8 months . was completed.

  • Company Incorporation

    Renuka Pharmaceuticals Private Limited was registered on 15 May 2009 with Roc Mumbai & aged 16 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Renuka Pharmaceuticals Private Limited?

The CIN of Renuka Pharmaceuticals Private Limited is U33100MH2009PTC192413.

Where is Renuka Pharmaceuticals Private Limited headquartered?

Renuka Pharmaceuticals Private Limited is headquartered at Shop No. 2A, Bal Ganpati Appartment Edalji Raod, Charai, Thane West, Maharashtra, 400601.

When was Renuka Pharmaceuticals Private Limited incorporated?

Renuka Pharmaceuticals Private Limited was incorporated on 15 May 2009.

Who are the current directors of Renuka Pharmaceuticals Private Limited?

The current directors of Renuka Pharmaceuticals Private Limited are

What is the primary industry of Renuka Pharmaceuticals Private Limited?

The primary industry of Renuka Pharmaceuticals Private Limited is Healthcare.

Is Renuka Pharmaceuticals Private Limited a listed company?

Renuka Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Renuka Pharmaceuticals Private Limited?

The authorized capital of Renuka Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available